Answers are grounded in this paper and cite their sources.
Research reports no toxicity from aqueous extract of Streblus asper in Sprague Dawley rats, indicating safety. Findings suggest potential for medicinal plant applications in healthcare.
The growing interest in the use of medicinal plants for treatment and healthcare necessitates thorough investigations into their safety profiles, many of which remain scarce. This research evaluates the acute toxicity of Streblus asper (SA) root aqueous extract, adhering to the OECD 420 testing guideline. Initially, a preliminary study administered increasing single doses of the extract, ranging from 5 up to 2000 mg/kg body weight, via oral gavage to female Sprague-Dawley rats. Following the determination of an appropriate starting dose, the main study included four additional rats. Over 14 days, subjects were monitored for mortality, toxicity signs, body weight and food consumption, followed by gross pathology analysis at the study's conclusion. The findings revealed no mortality or toxicity signs, consistent weight gain corresponding to food intake and no adverse effects on vital organs. Consequently, the study infers that the LD50 of SA root extract exceeds 2000 mg/kg body weight in rats, indicating a potentially safe profile for therapeutic applications. This research contributes valuable data on the safety of medicinal plants, supporting their integration into healthcare practices.
No takes yet. Share an insight, caveat, or question.
Mail et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: